Skip to main content
OpenTrials
Completed

NCT Number: NCT04622527

A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study

The purpose of this study is to evaluate the acceptability of using Virtual Reality intervention to help reduce anxiety and burnout symptoms and improve focus in the workplace.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

About this study

The proposed investigation will apply two novel paradigms using proprietary Virtual Reality interventions designed to reduce anxiety and inattention. We will explore whether this intervention is safe and acceptable, and whether it can impact the stress, anxiety, and difficulty in focus of employees in the workplace. Participants will view two different nature videos in two different formats. Each video will be experienced through Virtual Reality or non- Virtual Reality.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older at the time of consent.
  • Healthcare Professional with the Mayo Clinic.
  • Not pregnant by participant self-report at time of consent.
  • Have the ability to provide informed consent.
  • Have no contraindicated comorbid health conditions as determined by the clinical investigators.

Exclusion criteria

  • Currently (within the past 3 weeks) practicing mindfulness training on a weekly/regular basis.
  • Currently (within the past 3 weeks) undergoing an additional program (e.g., Complementary and Alternative Medicine [CAM]) to improve quality of life.
  • Currently (within 3 weeks) enrolled in another clinical or research program (e.g., CAM) which impacts the patients' quality of life (QOL), stress or anxiety.
  • Currently has photosensitivity.
  • Cannot tolerate virtual reality experiences.
  • An unstable medical or mental health condition as determined by the physician investigator (e.g., pre-existing eye strain, seizures, dizziness, nausea)

Treatment and study plan

Random assigned paradigm viewing order

Other

Participants experience the paradigm in a random order

Primary outcomes

  1. State-Trait Anxiety Inventory (STAI Y1)

    Time frame: 2 weeks

    STAI Y1 anxiety measurement of the change from post-test score to pre-test score.

    The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.

Secondary outcomes

  1. Was the Study Worthwhile

    Time frame: 2 weeks

    Acceptability of Virtual Reality measured by a question from the satisfaction survey done at the end of the study. The question asked was "Was it worthwhile for you to participate in this research study?".

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Relay Therapeutics, Inc.

Registry information

Official study title

Acceptability of Virtual Reality Experience by Health Care Providers for Improving Focus and Reducing Anxiety: A Pilot Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 10, 2020
Registry last updated
Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.